Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 2/2018

01-12-2018 | Research Article

Cost of Illness of Diabetic Foot Ulcer in a Resource Limited Setting: A Study from Northwestern Nigeria

Authors: Fakhraddeen Yahya Muhammad, Latifah Musa Pedro, Hassan Hassan Suleiman, Andrew E. Uloko, Ibrahim D. Gezawa, Enikuomehin Adenike, Mansur Ramalan, Garba Iliyasu

Published in: Journal of Diabetes & Metabolic Disorders | Issue 2/2018

Login to get access

Abstract

Introduction

Diabetic foot ulcer is a major complication of diabetes with a high economic cost of managing. Data from resource limited setting will bring to light how patients in these localities suffer financially in addition to poverty and lack of health insurance. This study estimated cost of illness among patients with diabetic foot ulcer in northwestern Nigeria.

Methods

It was a hospital based cross-sectional study. Questionnaire was used to take the bio data and medical history. Direct medical, direct non-medical and indirect cost were estimated.

Result

Majority of the patients were males with the mean age of 59.3 ± 15.1 yrs. About 60% of the patients earn less than $100 monthly. The total cost of illness of diabetic foot ulcer was estimated at $140,735.56 (median = $1381.55[IQR 1002.42-]). Direct cost of illness was $107,797.06 (median = $1023.27[IQR 773.93–1568]), while the indirect cost was $32,938.49 (median = $209.90[IQR 128.74–357.08]). Out of pocket payment accounted for 90% of the payment.

Conclusion

The cost of diabetic foot ulcer is very exorbitant and the patients affected are mostly poor, unemployed and the breadwinners of their families.
Literature
1.
go back to reference Yazdanapah L, Nasiri M, Adarvishi S. Literature review on the management of diabetic foot ulcer. World J Diabetes. 2015;6(1):37–53.CrossRef Yazdanapah L, Nasiri M, Adarvishi S. Literature review on the management of diabetic foot ulcer. World J Diabetes. 2015;6(1):37–53.CrossRef
2.
go back to reference National Institute for Health and Care Excellence. Diabetic foot problems: prevention and management. NICE guideline [NG19]. 2015. National Institute for Health and Care Excellence. Diabetic foot problems: prevention and management. NICE guideline [NG19]. 2015.
3.
go back to reference Bakri FG, Allan AH, Khader YS, et al. Prevalence of diabetic foot ulcer and its associated risk factors among diabetic patients in Jordan. J Med J. 2012;46(2):118–25. Bakri FG, Allan AH, Khader YS, et al. Prevalence of diabetic foot ulcer and its associated risk factors among diabetic patients in Jordan. J Med J. 2012;46(2):118–25.
4.
go back to reference Girod I, Valensi P, Laforet C, et al. An economic evaluation of the cost of diabetic foot ulcers: results of a retrospective study on 239 patients. Diabetes Metab. 2003;29(3):269–77.CrossRefPubMed Girod I, Valensi P, Laforet C, et al. An economic evaluation of the cost of diabetic foot ulcers: results of a retrospective study on 239 patients. Diabetes Metab. 2003;29(3):269–77.CrossRefPubMed
5.
7.
go back to reference Tchero H, Kangambega P, Lin L, Mukisi-Mukaza M, Brunet-Houdard S, Briatte C, et al. Cost of diabetic foot in France, Spain, Italy, Germany, and United Kingdom: a systematic review. Ann Endocrinol (Paris). 2018;79(2):67–74.CrossRef Tchero H, Kangambega P, Lin L, Mukisi-Mukaza M, Brunet-Houdard S, Briatte C, et al. Cost of diabetic foot in France, Spain, Italy, Germany, and United Kingdom: a systematic review. Ann Endocrinol (Paris). 2018;79(2):67–74.CrossRef
8.
go back to reference Peek ME. Gender Differences in Diabetes related Lower Extremity Amputations. Clin Orthop Relat Res. 2011;469(7):1951–5.CrossRefPubMed Peek ME. Gender Differences in Diabetes related Lower Extremity Amputations. Clin Orthop Relat Res. 2011;469(7):1951–5.CrossRefPubMed
9.
go back to reference Driver VR, Fabbi M, Lavery LA, Gibbons G. The costs of Diabetic foot: the economic case for the limb Salvage team. J Vasc Surg. 2010;52(3):17s–22s.CrossRefPubMed Driver VR, Fabbi M, Lavery LA, Gibbons G. The costs of Diabetic foot: the economic case for the limb Salvage team. J Vasc Surg. 2010;52(3):17s–22s.CrossRefPubMed
10.
go back to reference National Population Commission. State population. National Population Commission. State population.
11.
go back to reference World Medical Association (WMA) Declaration of Helsinki. Ethical principles for medical research involving human subjects. 59th WMA General Assembly, Seoul, Korea. 2008. World Medical Association (WMA) Declaration of Helsinki. Ethical principles for medical research involving human subjects. 59th WMA General Assembly, Seoul, Korea. 2008.
12.
go back to reference Dinh T, Veves A. The influence of gender as a risk factor in diabetic foot ulceration. Wounds. 2008;20(5):127–31.PubMed Dinh T, Veves A. The influence of gender as a risk factor in diabetic foot ulceration. Wounds. 2008;20(5):127–31.PubMed
13.
go back to reference Otiano ME, Du X, Ottenbacher K, et al. Lower extremity amputations in Diabetic Mexican American elders: incidence, prevalence and correlates. J Diabetes Complications. 2003;17(2):59–65.CrossRef Otiano ME, Du X, Ottenbacher K, et al. Lower extremity amputations in Diabetic Mexican American elders: incidence, prevalence and correlates. J Diabetes Complications. 2003;17(2):59–65.CrossRef
14.
go back to reference Ngwogu KO, Umez-Emeana EC, Ngwogu AC. The burden of diabetic foot ulcers in aba, Abia State Nigeria. IJBAIR. 2013;2(4):118–24. Ngwogu KO, Umez-Emeana EC, Ngwogu AC. The burden of diabetic foot ulcers in aba, Abia State Nigeria. IJBAIR. 2013;2(4):118–24.
15.
go back to reference Al-Rubean K, Al-Derwish M, Ouizi S, et al. Diabetic foot complications and their risk factors from a large retrospective cohort study. PLoS One. 2015;10(5):e0124446.CrossRef Al-Rubean K, Al-Derwish M, Ouizi S, et al. Diabetic foot complications and their risk factors from a large retrospective cohort study. PLoS One. 2015;10(5):e0124446.CrossRef
16.
go back to reference Shobhana R, Rao PR, Lavanya A, et al. Foot care economics-cost burden to diabetic patients with foot complications: a study from southern India. J Assoc Physicians India. 2001;49:530–3.PubMed Shobhana R, Rao PR, Lavanya A, et al. Foot care economics-cost burden to diabetic patients with foot complications: a study from southern India. J Assoc Physicians India. 2001;49:530–3.PubMed
17.
go back to reference The World Bank. Poverty and Equity. The World Bank Group. 2017. The World Bank. Poverty and Equity. The World Bank Group. 2017.
18.
go back to reference Kumar S, Ashe HA, Parnel LN. The prevalence of foot ulcers and its correlates in type 2 diabetic patients: a population-based study. Diabet Med. 1994;11:480–4.CrossRefPubMed Kumar S, Ashe HA, Parnel LN. The prevalence of foot ulcers and its correlates in type 2 diabetic patients: a population-based study. Diabet Med. 1994;11:480–4.CrossRefPubMed
19.
go back to reference Cavanagh P, Attinge C, Abbas Z, Bal A, et al. Cost of treating diabetic foot ulcers in five different countries. Diabetes Metab Res Rev. 2012;28(1):107–11.CrossRefPubMed Cavanagh P, Attinge C, Abbas Z, Bal A, et al. Cost of treating diabetic foot ulcers in five different countries. Diabetes Metab Res Rev. 2012;28(1):107–11.CrossRefPubMed
20.
go back to reference Ogbera AO, Fasanmade O, Onwovorhiole AE, Adediran O. An assessment of the disease burden of foot ulcers in patients with diabetes mellitus attending a teaching hospital in Lagos, Nigeria. Int J Low Extrem Wounds. 2006;5(4):244–9.CrossRefPubMed Ogbera AO, Fasanmade O, Onwovorhiole AE, Adediran O. An assessment of the disease burden of foot ulcers in patients with diabetes mellitus attending a teaching hospital in Lagos, Nigeria. Int J Low Extrem Wounds. 2006;5(4):244–9.CrossRefPubMed
21.
go back to reference Holzer SE, Camerota A, Martens L, et al. Costs and duration of care for lower extremity ulcers in patients with diabetes. Clin Ther. 1998;20:169–81.CrossRefPubMed Holzer SE, Camerota A, Martens L, et al. Costs and duration of care for lower extremity ulcers in patients with diabetes. Clin Ther. 1998;20:169–81.CrossRefPubMed
22.
go back to reference Ramsey SD, Newton K, Blough D, et al. Incidence, Outcoes and cost of foot ulcers in patients with Diabetes. Diabetes Care. 1999;22(3):382–7.CrossRefPubMed Ramsey SD, Newton K, Blough D, et al. Incidence, Outcoes and cost of foot ulcers in patients with Diabetes. Diabetes Care. 1999;22(3):382–7.CrossRefPubMed
23.
go back to reference Harrington C, Zagari MJ, Corea J, Klintenic JA. Cost analysis of lower extremity ulcers. Diabetes Care. 2000;23:1333–8.CrossRefPubMed Harrington C, Zagari MJ, Corea J, Klintenic JA. Cost analysis of lower extremity ulcers. Diabetes Care. 2000;23:1333–8.CrossRefPubMed
24.
go back to reference Stockl K, Vanderplas A, Tafesse E, Chang E. Costs of lower extremity ulcers among patients with diabetes. Diabetes Care. 2004;27(9):2129–34.CrossRefPubMed Stockl K, Vanderplas A, Tafesse E, Chang E. Costs of lower extremity ulcers among patients with diabetes. Diabetes Care. 2004;27(9):2129–34.CrossRefPubMed
25.
go back to reference Apelqvist J, Ragnarson-Tennvall G, Persson U, Larsson J. Diabetic foot ulcers in a multidisciplinary setting. An economic analysis of main healing and healing with amputation. J Intern Med. 1994;235:463–71.CrossRefPubMed Apelqvist J, Ragnarson-Tennvall G, Persson U, Larsson J. Diabetic foot ulcers in a multidisciplinary setting. An economic analysis of main healing and healing with amputation. J Intern Med. 1994;235:463–71.CrossRefPubMed
26.
go back to reference Gordois A, Oglesby A, Scuffham P, et al. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care. 2003;26(6):1790–5.CrossRefPubMed Gordois A, Oglesby A, Scuffham P, et al. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care. 2003;26(6):1790–5.CrossRefPubMed
27.
go back to reference Van Acker K, Leger P, Hartemann A, et al. Burden of foot disorders, guidelines for management and disparities in implementation in Europe: a systematic literature review. Diabetes Metab Res Rev. 2014;30(8):635–45.CrossRefPubMed Van Acker K, Leger P, Hartemann A, et al. Burden of foot disorders, guidelines for management and disparities in implementation in Europe: a systematic literature review. Diabetes Metab Res Rev. 2014;30(8):635–45.CrossRefPubMed
28.
29.
go back to reference Girod I, Valensi P, Laforet C, et al. An economic evaluation of the cost of diabetic foot ulcers: results of a retrospective study on 239 patients. Diabetes Metab. 2003;29(3):269–77.CrossRefPubMed Girod I, Valensi P, Laforet C, et al. An economic evaluation of the cost of diabetic foot ulcers: results of a retrospective study on 239 patients. Diabetes Metab. 2003;29(3):269–77.CrossRefPubMed
30.
go back to reference Rice JB, Desai U, Cummings AK, et al. Burden of diabetic foot ulcers for Medicare and private insurers. Diabetes Care. 2013; Rice JB, Desai U, Cummings AK, et al. Burden of diabetic foot ulcers for Medicare and private insurers. Diabetes Care. 2013;
31.
go back to reference Boulton AJ, Kumar S, Ashe HA, et al. High prevalence of risk factors for foot ulcers in type 2 diabetic patients: a population based study. Diabetologia. 1992;35:A158. Boulton AJ, Kumar S, Ashe HA, et al. High prevalence of risk factors for foot ulcers in type 2 diabetic patients: a population based study. Diabetologia. 1992;35:A158.
32.
go back to reference Apelqvist J, Ragnarson-Tennvall G, Persson U, Larsson J. Foot ulcers in diabetic patients in a multidisciplinary setting. Foot Ankle Int. 1995;16(7):388–94.CrossRefPubMed Apelqvist J, Ragnarson-Tennvall G, Persson U, Larsson J. Foot ulcers in diabetic patients in a multidisciplinary setting. Foot Ankle Int. 1995;16(7):388–94.CrossRefPubMed
33.
go back to reference Hicks CW, Selvarajah S, Mathioudakis N, et al. Trends and determinants of costs associated with the inpatient care of diabetic foot ulcers. J Vasc Surg. 2014;6(5):1247–54.CrossRef Hicks CW, Selvarajah S, Mathioudakis N, et al. Trends and determinants of costs associated with the inpatient care of diabetic foot ulcers. J Vasc Surg. 2014;6(5):1247–54.CrossRef
Metadata
Title
Cost of Illness of Diabetic Foot Ulcer in a Resource Limited Setting: A Study from Northwestern Nigeria
Authors
Fakhraddeen Yahya Muhammad
Latifah Musa Pedro
Hassan Hassan Suleiman
Andrew E. Uloko
Ibrahim D. Gezawa
Enikuomehin Adenike
Mansur Ramalan
Garba Iliyasu
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
Journal of Diabetes & Metabolic Disorders / Issue 2/2018
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-018-0344-8

Other articles of this Issue 2/2018

Journal of Diabetes & Metabolic Disorders 2/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.